Literature DB >> 6883910

Plasma clonidine levels in hypertension.

M T Velasquez, J Rho, R F Maronde, J Barr.   

Abstract

Ten patients with essential hypertension were treated orally with clonidine, and the dose was titrated until the diastolic pressure fell below 90 mm Hg or at least 10 mm Hg below baseline, or until a maximum dose of clonidine of 1.2 mg/day was reached. After at least 2 wk on a constant dose of clonidine, the patients were hospitalized and blood pressure and plasma clonidine concentrations were measured by a highly specific and sensitive gas chromatographic, electron-capture method (sensitivity as low as 0.1 ng clonidine/ml). There was good correlation between daily clonidine dose and plasma clonidine concentration. The average blood pressure reduction during 12 hr after clonidine correlated poorly with steady-state plasma levels of clonidine, but when the individual maximum decrease in mean blood pressure was paired with the corresponding peak plasma concentration of clonidine, the correlation was strong.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6883910     DOI: 10.1038/clpt.1983.177

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  2 in total

1.  CYP2D6 mediates 4-hydroxylation of clonidine in vitro: implication for pregnancy-induced changes in clonidine clearance.

Authors:  Adam J Claessens; Linda J Risler; Sara Eyal; Danny D Shen; Thomas R Easterling; Mary F Hebert
Journal:  Drug Metab Dispos       Date:  2010-06-22       Impact factor: 3.922

Review 2.  Clinical pharmacokinetics of clonidine.

Authors:  D T Lowenthal; K M Matzek; T R MacGregor
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.